Tritonpoint Wealth LLC Increases Position in iShares Biotechnology ETF (NASDAQ:IBB)

Tritonpoint Wealth LLC increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 6.6% during the fourth quarter, Holdings Channel reports. The institutional investor owned 2,004 shares of the financial services provider’s stock after acquiring an additional 124 shares during the period. Tritonpoint Wealth LLC’s holdings in iShares Biotechnology ETF were worth $265,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets raised its position in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the last quarter. Aprio Wealth Management LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter valued at $18,476,000. DRW Securities LLC purchased a new position in iShares Biotechnology ETF during the third quarter worth $5,990,000. Finally, Erste Asset Management GmbH acquired a new position in shares of iShares Biotechnology ETF in the third quarter worth $5,678,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.2 %

IBB opened at $138.66 on Monday. The business’s fifty day simple moving average is $136.37 and its 200 day simple moving average is $141.55. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.